secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2021-07-09T23:59:59+00:00
Accession:  0001193125-21-211337
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Verrica Pharmaceuticals appoints Terry Kohler as CFO, replacing Brian Davis effective July 16, 2021
--------------------------------------------------------------------------------

- Brian Davis terminated as CFO effective July 16, 2021; eligible for severance subject to separation agreement.
- Terry Kohler appointed CFO effective July 16, 2021; previously VP of Corporate Development and Treasurer at Endo.
- Kohler receives $350,000 base salary, 40% target bonus, and option to purchase 125,000 shares vesting over 4 years.
- Kohler holds an MBA from UNC Chapel Hill and is a Certified Management Accountant.
- Employment at-will; severance provisions vary based on timing and change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312521211337/0001193125-21-211337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312521211337/d181869d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-211337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer